Altus Biologics Inc., Cambridge, Mass., said it has raised $35 million in private financing. Nomura International and U.S. Venture Partners were the lead investors, joined by BankInvest and ...

Altus Pharmaceuticals Inc., the former Waltham drug maker that filed for Chapter 7 bankruptcy in November and has since ceased operations, has had its intellectual property portfolio and protein ...

Altus Biologics Inc., a Cambridge biotech company, has sold the European marketing rights of a drug it is developing to help treat cystic fibrosis patients. A German pharmaceutical company ...

Altus Capital Partners has acquired Knoxville, Tennessee-based ChoiceSpine LP, a maker of of specialized spinal implants, instrumentation and biologics for the surgical treatment of complex spine ...

Specialized implant manufacturer ChoiceSpine was acquired by Altus Capital Partners ... interbody and lateral implants, as well as biologics kits. “ChoiceSpine, a global medical device ...